Shares jumped by 8% as HCA holdings posted interim second quarter results implying growth inpatient volume and net revenue gain. Same facility admissions grew 1.2% and case mix increased at rate of 1.7%. A same facility equivalent admission increased by 2.2% and same facility revenue per equivalent admission is likely to grow at 5.4%.
According to preliminary results, revenues are expected to grow at 9.2% year over year to $9.23 billion. Analysts project EPS to be $1.07 with 17.6% growth rate. Looking into 2014 guidance, HCA projects revenues to range in between $36 billion and $36.5 billion. Experts estimate that the adjusted EPS should fall in between $4.00 and $4.25. The results seem quite positive and currently HCA is trading at $62.52, which is fourteen times of the fiscal year EPA estimate according to some sources.